Research Projects
Synergistic combinations in cancer immunotherapy of agonist agents that interfere with pro-tumor inflammation
Researcher | Principal Investigator
Combination Strategies for Translational Immunotherapy Research Group
Research Division
Cancer Division
Research program
Immunology and Immunotherapy
Research group
Combined translational immunotherapy strategies
Project information
“Synergistic combinations in cancer immunotherapy using agonist agents that interfere with pro-tumor inflammation” is a project by the Combined Strategies in Translational Immunotherapy research group, part of the Immunology and Immunotherapy program.
Project PID2023-147515OB-I00 funded by:
- Convocation: Proyectos de Generación de Conocimiento 2023
- Reference: PID2023-147515OB-I00
- Start date: September 1, 2024
- End date: August 31, 2027
- Nature of project: National
Need more information?
If you are interested in learning more about our research, please contact us.